PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Researchers discover treatment for rare blood cancer

2014-01-30
(Press-News.org) Contact information: Patrick McGeer
mcgeerpl@mail.ubc.ca
604-822-7377
University of British Columbia
Researchers discover treatment for rare blood cancer University of British Columbia researchers have discovered a potential new treatment for a rare blood cancer that may also point the way to treating other more common diseases.

Paroxysmal nocturnal hemoglobinemia (PNH) is a rare form of cancer characterized by episodic rupture of red blood cells and the danger of blood clots forming in the vascular system. The condition results in red blood cells becoming vulnerable to attacks by the body's own complement immune system and can lead to complications such as anemia, kidney disease and fatal thromboses.

In a clinical study published today in PLOS ONE, the UBC team, led by Prof. Patrick McGeer, applied aurin tricarboxylic acid (ATA), a non-toxic drug, to blood samples of five patients with PNH who were undergoing standard treatment with antibodies administered through biweekly infusions.

The researchers found the addition of ATA restored blood cell resistance to complement system attacks, while the antibodies alone did not offer full protection.

"Our study suggests that ATA could offer more complete protection as an oral treatment for PNH while eliminating the need for infusions," says Prof. McGeer, professor emeritus in UBC's Department of Psychiatry. "PNH is a disease that may happen to anyone through a chance mutation, and if nature were to design a perfect fix for this mutation, it would be ATA."

McGeer adds that since many diseases are caused or worsened by an overactive complement immune system, the discovery of ATA's effectiveness in this rare disease could have wide-reaching implications for conditions such as Alzheimer's and Parkinson disease, macular degeneration, ALS, multiple sclerosis and rheumatoid arthritis.

The team is now proceeding with further testing and McGeer hopes the treatment may be available in clinics within a year.

INFORMATION:

BACKGROUND | TREATMENT FOR RARE CANCER

PNH and ATA

The Paroxysmal nocturnal hemoglobinemia (PNH) mutation leaves cells deficient in two critical proteins – called protectin and decay accelerating factor – that in healthy individuals shield the red blood cells from self-attack by the complement system. Aurin tricarboxylic acid (ATA) works by blocking this self-attack and thus compensating for this deficiency.

Study team

Members of the study team were Dr. Sujaatha Nariyanan of the British Columbia Cancer Agency, and Drs Moonhee Lee, Edith McGeer and Patrick McGeer of UBC's Kinsmen Laboratory of Neurological Research.

END



ELSE PRESS RELEASES FROM THIS DATE:

Scientists shine spotlight on Herdwicks' origins

2014-01-30
A new study highlights surprising differences between Herdwick sheep and their closest neighbouring UK upland breeds. The research, led by The Sheep Trust, a national charity based at the University of York, is ...

Sponge bacteria, a chemical factory

2014-01-30
Sponges are unique beings: they are invertebrates that live in symbiosis with sometimes hundreds of different types of bacteria; similar to lichens which are a biocoenosis of algae and fungi. "Put simply, many ...

Improved ultrasound imaging provides alternate way to visualize tumors

2014-01-30
CHAPEL HILL, NC – While ultrasound ...

Neanderthal lineages excavated from modern human genomes

2014-01-30
A substantial fraction of the Neanderthal genome persists in modern human populations. A new approach applied to analyzing whole-genome ...

More heart attack patients being treated more quickly using PCI , national audit finds

2014-01-30
Expansion in the use of Percutaneous Coronary Intervention (PCI) – the minimally ...

'Rogue' asteroids may be the norm

2014-01-30
CAMBRIDGE, MA -- To get an idea of how the early solar system may have formed, scientists often look to asteroids. These relics of rock and dust represent what today's planets may have been before they differentiated ...

When populations collide

2014-01-30
More than thirty thousand years ago, Homo sapiens migrating out of Africa began encountering Neanderthals, a lineage that had diverged from modern humans hundreds of thousands ...

TRMM satellite peers at rainfall in developing low near Mozambique

2014-01-30
PUBLIC RELEASE DATE: 29-Jan-2014 [ | E-mail ] var addthis_pub="eurekalert"; var addthis_options = "favorites, delicious, digg, facebook, twitter, google, newsvine, reddit, slashdot, stumbleupon, buzz, more" Share Contact: Rob Gutro robert.j.gutro@nasa.gov NASA/Goddard Space Flight Center TRMM satellite peers at rainfall in developing low near Mozambique VIDEO: The TRMM satellite flew above a tropical low (91S) in the Mozambique Channel on Jan. 28, 2014, ...

NASA-NOAA satellite sees Tropical Cyclone 11P headed for Queensland

2014-01-30
The NASA-NOAA Satellite known as Suomi NPP flew over newborn Tropical Cyclone 11P in the Coral Sea and captured a visible image of the newly developed storm as it moves toward a landfall in Queensland, ...

UA researchers trace bat killer's path

2014-01-30
As North American bats face a death toll approaching 7 million, University of Akron scientists reveal new clues about their killer, White Nose Syndrome, ...

LAST 30 PRESS RELEASES:

“Sloshing” from celestial collisions solves mystery of how galactic clusters stay hot

Children poisoned by the synthetic opioid, fentanyl, has risen in the U.S. – eight years of national data shows

USC researchers observe mice may have a form of first aid

VUMC to develop AI technology for therapeutic antibody discovery

Unlocking the hidden proteome: The role of coding circular RNA in cancer

Advancing lung cancer treatment: Understanding the differences between LUAD and LUSC

Study reveals widening heart disease disparities in the US

The role of ubiquitination in cancer stem cell regulation

New insights into LSD1: a key regulator in disease pathogenesis

Vanderbilt lung transplant establishes new record

Revolutionizing cancer treatment: targeting EZH2 for a new era of precision medicine

Metasurface technology offers a compact way to generate multiphoton entanglement

Effort seeks to increase cancer-gene testing in primary care

Acoustofluidics-based method facilitates intracellular nanoparticle delivery

Sulfur bacteria team up to break down organic substances in the seabed

Stretching spider silk makes it stronger

Earth's orbital rhythms link timing of giant eruptions and climate change

Ammonia build-up kills liver cells but can be prevented using existing drug

New technical guidelines pave the way for widespread adoption of methane-reducing feed additives in dairy and livestock

Eradivir announces Phase 2 human challenge study of EV25 in healthy adults infected with influenza

New study finds that tooth size in Otaria byronia reflects historical shifts in population abundance

nTIDE March 2025 Jobs Report: Employment rate for people with disabilities holds steady at new plateau, despite February dip

Breakthrough cardiac regeneration research offers hope for the treatment of ischemic heart failure

Fluoride in drinking water is associated with impaired childhood cognition

New composite structure boosts polypropylene’s low-temperature toughness

While most Americans strongly support civics education in schools, partisan divide on DEI policies and free speech on college campuses remains

Revolutionizing surface science: Visualization of local dielectric properties of surfaces

LearningEMS: A new framework for electric vehicle energy management

Nearly half of popular tropical plant group related to birds-of-paradise and bananas are threatened with extinction

The changing chorus: How movements and memories influence birdsong evolution

[Press-News.org] Researchers discover treatment for rare blood cancer